research
Radiologic staging of esophageal and gastroesophageal junction carcinoma
- Publication date
- 30 June 1993
- Publisher
- Pretreatment radiologic staging can, theoretically, improve the effectiveness and results
of surgical treatment in esophageal and gastroesophageal junction carcinoma. Ideally, on
these studies it is possible to select only patients with limited local disease for surgery,
whereas those with nonresecta.ble tumors or metastases to distant sites are excluded
from surgery and submitted to other treatment modalities. The purpose of this study was to evaluate the utility of CT, US and US-guided FNAB for pretreatment staging of
esophageal and gastroesophageal junction carcinoma. In assessing distant metastases,
these techniques were evaluated at different sites, Because little has been published
regarding the examination of supraclavicular lymph nodes in esophageal and
gastroesophageal junction carcinoma, a retrospective stndy was first performed to
determine the number of patients with squamous cell carcinoma of the intrathoracic
esophagus in whom supraclavicular metastases could be demonstrated with us and usguided
FNAB (Chapter 2), Subsequently, palpation, CT and US were prospectively
evaluated for assessing supraclavicular metastases in patients with either esophageal or
gastroesophageal junction carcinoma (Chapter 3). Accuracy of either CT, US, or a
combination of both studies, to assess distant metastases in general and at the various
sites was determined (Chapter 4). The utility of US-guided FNAB for diagnosing
metastases was evaluated (Chapter 5). Assessment of resectability of the primary tnmor
was analyzed on CT stndies alone because, generally, this cannot be displayed on US
stndies (Chapter 6). Finally a survival analysis was performed to estimate the influence
on survival of distant metastases, assessed on US or CT studies, or diagnosed by means
of US-guided FNAB and cytologic stndy (Chapter 7).